Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cytochrome P450 17 (CYP17) Inhibitor developme...
Jan 2019 $ 1250
Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Diglyceride Acyltransferase (DGAT) Inh...
Jan 2019 $ 1250
Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Dihydroorotate Dehydrogenase (DHODH)...
Jan 2019 $ 1250
DNA Methyltransferase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA Methyltransferase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA Methyltransferase Inhibitor development. The re...
Jan 2019 $ 1250
DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA-Dependent RNA Polymerase Inhibitor devel...
Jan 2019 $ 1250
DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019
By Delve Insight
"DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeut...
Jan 2019 $ 1250
Eg5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Eg5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Eg5 Inhibitor development. The report provides detailed coverage of t...
Jan 2019 $ 1250
Elastase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Elastase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Elastase Inhibitor development. The report provides detailed cov...
Jan 2019 $ 1250
Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor (ET) Antagonist development...
Jan 2019 $ 1250
Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor A (ETA) Antagonist devel...
Jan 2019 $ 1250
Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Enhancer of zeste homolog 2 (EZH2) Inh...
Jan 2019 $ 1250
Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Ephrin Type A Recept...
Jan 2019 $ 1250
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Epithelial Sodium Channel (ENaC) Inhibit...
Jan 2019 $ 1250
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019
By Delve Insight
"Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Estrogen Receptor Beta Partial Agonist devel...
Jan 2019 $ 1250
Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor II (Prothrombin) Inhibitor development. Th...
Jan 2019 $ 1250
Factor IX - Pipeline Insight, 2019
By Delve Insight
"Factor IX - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX development. The report provides detailed coverage of the pipel...
Jan 2019 $ 1250
Factor IX A Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor IX A Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX A Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Factor VIIa Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIIa Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor VIIa Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Factor VIII Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIII Inhibitor - Pipeline Insights, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Factor VIII Inhibitor. A detailed picture of the pipeline landscape is provided with summation of ...
Jan 2019 $ 1250
Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019
By Delve Insight
"Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Farnesoid X Receptor (FXR) Agonist development. ...
Jan 2019 $ 1250
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Amide Hydrolase (FAAH) Inhib...
Jan 2019 $ 1250
Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Synthase (FAS) Inhibitor development...
Jan 2019 $ 1250
Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fc-Gamma Receptor Antagonist development. The report p...
Jan 2019 $ 1250
Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Activation Prot...
Jan 2019 $ 1250
Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor (FGF) Inhibitor d...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy